EXACT SCIENCES CORP Asset Impairment Charges
EXACT SCIENCES CORP reported Asset Impairment Charges of $7.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2026-02-13
- EXACT SCIENCES CORP asset impairment charges for the quarter ending 2025-12-31 was $406.00K, a 99.95% decline year-over-year.
- EXACT SCIENCES CORP asset impairment charges for the quarter ending 2025-09-30 was $543.00K, a 97.10% decline year-over-year.
- EXACT SCIENCES CORP asset impairment charges for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- EXACT SCIENCES CORP asset impairment charges for the quarter ending 2025-03-31 was $6.25M, a 40.60% increase year-over-year.
- EXACT SCIENCES CORP asset impairment charges for fiscal 2025 was $7.20M, a 99.17% decline from fiscal 2024.
- EXACT SCIENCES CORP asset impairment charges for fiscal 2024 was $869.46M, a 139909.66% increase from fiscal 2023.
- EXACT SCIENCES CORP asset impairment charges for fiscal 2023 was $621.00K, a 96.11% decline from fiscal 2022.
- EXACT SCIENCES CORP asset impairment charges for fiscal 2022 was $15.97M.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $949.00K derived: sum of 2 quarters · filed 2026-02-13 | $949.00K derived: sum of 3 quarters · filed 2026-02-13 | $7.20M 10-K · filed 2026-02-13 |
| 2025-09-30 | $543.00K 10-Q · filed 2025-11-03 | $543.00K derived: sum of 2 quarters · filed 2025-11-03 | $6.79M 10-Q · filed 2025-11-03 | $844.96M derived: sum of 4 quarters · filed 2025-11-03 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | $6.25M 10-Q · filed 2025-08-06 | $844.41M derived: sum of 3 quarters · filed 2025-08-06 | $863.12M derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $6.25M 10-Q · filed 2025-05-01 | $844.41M derived: sum of 2 quarters · filed 2025-05-01 | $863.12M derived: sum of 3 quarters · filed 2026-02-13 | $871.27M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $838.16M 10-K · filed 2025-02-19 | $856.86M derived: sum of 2 quarters · filed 2026-02-13 | $865.02M derived: sum of 3 quarters · filed 2026-02-13 | $869.46M 10-K · filed 2026-02-13 |
| 2024-09-30 | $18.70M 10-K · filed 2026-02-13 | $26.85M derived: sum of 2 quarters · filed 2026-02-13 | $31.30M 10-Q · filed 2025-11-03 | $31.30M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $8.15M 10-Q · filed 2025-08-06 | $12.60M 10-Q · filed 2025-08-06 | $12.60M derived: sum of 3 quarters · filed 2025-08-06 | $12.60M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $4.45M 10-Q · filed 2025-05-01 | $4.45M derived: sum of 2 quarters · filed 2025-05-01 | $4.45M derived: sum of 3 quarters · filed 2025-05-01 | $5.00M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-19 | $0.00 derived: sum of 2 quarters · filed 2025-02-19 | $552.00K derived: sum of 3 quarters · filed 2025-02-19 | $621.00K 10-K · filed 2026-02-13 |
| 2023-09-30 | $0.00 10-K · filed 2025-02-19 | $552.00K derived: sum of 2 quarters · filed 2025-02-19 | $621.00K derived: sum of 3 quarters · filed 2025-02-19 | |
| 2023-06-30 | $552.00K 10-K · filed 2025-02-19 | $621.00K derived: sum of 2 quarters · filed 2025-02-19 | ||
| 2023-03-31 | $69.00K 10-K · filed 2025-02-19 | |||
| 2022-12-31 | $15.97M 10-K · filed 2025-02-19 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $0.00 10-Q · filed 2020-07-31 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | |||
| 2019-12-31 | $0.00 10-Q · filed 2020-07-31 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-21 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-21 |